Further to DrugAlert vol 805, HPS Pharmacies wish to advise that suppliers are continuing to experience a supply interruption for metronidazole tablets and suspension as follows:

Product ARTG Estimated return date
Metrogyl® 200mg 17654 End-October 2022
Metrogyl® 400mg 17655 End-October 2022
Flagyl® 200mg 160171 Discontinued
Flagyl® 400mg 160174 Mid-November 2022
Metronide® 200mg 160173 Discontinued
Metronide® 400mg 160175 Discontinued
Flagyl® S Suspension 27501 Mid-late October 2022

An internationally registered brand of metronidazole 400mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Supplies of metronidazole for injection are currently unaffected by this shortage.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates